Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

Clinical trial NCT00002734 · COMPLETED

Trial details

NCT number: NCT00002734
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1996-03-01
Primary completion: 2001-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.